Literature DB >> 17544577

Photolytic (UVC) and photocatalyic (UVC/TiO2) decomposition of pyridines.

David R Stapleton1, Dionissios Mantzavinos, Maria Papadaki.   

Abstract

The degradation of 2-chloropyridine (2-CPY) and its degradation primary product 2-hydroxypyridine (2-HPY) was studied by means of ultraviolet (UV) irradiation at 254nm. Photolytic and photocatalytic experiments were conducted on 2-CPY and 2-HPY aqueous solutions in a batch reactor with internal recycle in laminar and turbulent conditions at 50 degrees C in a closed but not airtight system with and without additional aeration, at solution ambient pH and at controlled pH conditions, with use and in the absence of radical scavenger. The solution volume was 0.4L and initial substrate concentrations were approximately 2.6mmol/L (0.25-0.3g/L depending on the substrate). Where applicable 1g/L TiO(2) (P-25) was used, suspended in the liquid in a form of turbulent slurry or using a glass tube around the UV-lamp on which a fixed TiO(2) catalytic layer had been deposited. At the aforementioned conditions 2-CPY readily degrades photolytically, the catalytic path having very little influence. In all cases 2-CPY produces 2-HPY which further degrades to other products. Aeration, pH and the presence of catalyst and/or radical scavengers do not affect the rate of decomposition of 2-CPY, but have a strong influence on the further decomposition of the produced 2-HPY. 2-HPY decomposition proceeds both catalytically and photolytically following oxygen dependent and oxygen independent pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544577     DOI: 10.1016/j.jhazmat.2007.04.067

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  1 in total

1.  Merits of photocatalytic and antimicrobial applications of gamma-irradiated Co x Ni1-x Fe2O4/SiO2/TiO2; x = 0.9 nanocomposite for pyridine removal and pathogenic bacteria/fungi disinfection: implication for wastewater treatment.

Authors:  Gharieb S El-Sayyad; M Abd Elkodous; Ahmed M El-Khawaga; Mohamed A Elsayed; Ahmed I El-Batal; Mohamed Gobara
Journal:  RSC Adv       Date:  2020-02-03       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.